- Home
- CNVS vs MNOV Comparison
CNVS vs MNOV Comparison
Compare CNVS & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNVS | MNOV |
|---|---|---|
| Founded | 2000 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.5M | 72.7M |
| IPO Year | 2016 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CNVS | MNOV |
|---|---|---|
| Price | $2.42 | $1.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $9.00 | $8.00 |
| AVG Volume (30 Days) | ★ 321.0K | 61.4K |
| Earning Date | 02-17-2026 | 02-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $78,181,000.00 | $2,360,807.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $84.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 59.13 | ★ 194.15 |
| 52 Week Low | $1.77 | $1.13 |
| 52 Week High | $7.39 | $1.96 |
Technical Indicators
Market Signals| Indicator | CNVS | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 41.20 | 46.52 |
| Support Level | $2.37 | $1.40 |
| Resistance Level | $3.47 | $1.43 |
| Average True Range (ATR) | 0.23 | 0.07 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 1.26 | 48.08 |
Price Performance
Historical ComparisonAbout CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.